SPACInsider Logo
The Latest SPAC News and Rumors: December 1, 2022
by Marlena Haddad on 2022-12-01 at 11:25am

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs


NYSE president says IPO proceeds fall more than 90%

Volatility and market uncertainty have taken a big hit on the number of companies going public, driving down initial public offering proceeds by 93% this year, Lynn Martin, president of the New York Stock Exchange said on Wednesday.

“There is a lot of uncertainty and there’s a lot of different forces that are impacting markets,” said Martin during an interview at the Reuters NEXT conference.

Last year was a record for IPOs at the NYSE, fueled in large part by the boom in special purpose acquisition companies, but that activity has slowed to a trickle as high inflation and rising interest rates have soured market sentiment and SPACs have drawn regulatory scrutiny.

READ

Nasdaq CEO hopeful IPOs will pick up in 2023, calls for more crypto regulation

Adena Friedman, chief executive officer of Nasdaq Inc., said on Wednesday she expects a quiet first half of 2023 for initial public offerings as investors remain cautious, but is hopeful activity will pick up in the second half of the year.

There are currently about 200 companies in the pipeline for initial public offerings on the Nasdaq, which is below the range of the last few years of 250 to 300, Friedman said during an interview at the Reuters NEXT conference.

Last year was a banner year for IPOs at Nasdaq with over 750 new listings, fueled in large part by the boom in special purpose acquisition companies, but that activity has slowed to a trickle as high inflation and rising interest rates have soured market sentiment and SPACs have drawn regulatory scrutiny.

READ

Brothers Who Made Billions on US Pharma Firm Revamp Health Bets

The Giulianis are selling Royalty Pharma stock as they invest in other health-focused firms, including a SPAC that merged with biotech business ProKidney (Nasdaq: PROK).

The brothers have started cutting their roughly $2.4 billion stake in Royalty Pharma for the first time since its New York listing more than two years ago.  Their investment funds have filed to sell up to almost $100 million of stock in the company, which buys pharmaceutical royalties, after offloading about $150 million — or roughly 6% of the holding — in recent months.

Germano, 50, and Giammaria, 44, have meanwhile made more than a dozen investments worldwide this year, mostly in health-related companies.  They poured at least $22 million into a blank-check firm co-founded by Chamath Palihapitiya that merged in July with biotech business ProKidney Corp., as well as $16 million into biotech startup ReNAgade Therapeutics and nutrition company BioLumen.


 

Recent Posts
by Kristi Marvin on 2023-02-04 at 12:57am

Terms Tracker for the Week Ending February 3, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The month of February started with an IPO, thanks to the pricing of Cetus Capital Acquisition Corp (Nasdaq: CETU) which began trading on February 1....

by Marlena Haddad on 2023-02-03 at 5:50pm

Forest Road II (NYSE:FRXB) and 10X Capital Venture III (NYSE:VCXB) both announced this afternoon that they have mutually terminated their business combinations. Forest Road II intended to combine with transportation technology developer HyperloopTT, but the parties decided to nix the deal due to timing constraints along with unfavorable market conditions. Tom Staggs and Kevin Mayer, Co-CEOs and...

by Marlena Haddad on 2023-02-03 at 5:30pm

Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) and AMCI Acquisition Corp. II (Nasdaq: AMCI) announced this afternoon that they have adjourned their special meetings with shareholders. Intelligent Medicine originally scheduled its meeting to be held today, but is now postponing its vote until Wednesday, February 8. Stockholders may elect to redeem their shares by no later than...

by Marlena Haddad on 2023-02-03 at 11:41am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Comcast dumps 18.5% of its BuzzFeed stock Comcast Dumps 6 Million Shares of Buzzfeed After Media Company Finally Gets a Bump Comcast dumped 18.5% of its BuzzFeed (NASDAQ:BZFD) stock in recent days, reducing its...

by Nicholas Alan Clayton on 2023-02-03 at 11:37am

Viveon Health (NYSE:VHAQ) announced this morning that it is unilaterally terminating its combination with Suneva Medical “based upon material breaches” of the merger agreement. The SPAC did not elaborate further on its claims against Suneva, but noted it will continue on and seek a new business combination. Just last week, Viveon Health was working to...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved